Centrex Ltd News - CXM

Professional-Grade Tools, for Individual Investors.

Cardium Announces Planned Release of Data from Matrix Excellarate Phase 2b Clinical Study and Acceptance of Phase 1 / 2 Study fo

SAN DIEGO, Oct. 1 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) announced plans to report on preliminary safety and efficacy...

Cardium Announces $4.5 Million Common Stock Private Placement

SAN DIEGO, Sept. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced a common stock private placement to selected...

Scientific Journal Gene Therapy Reports That Cardium's Gene Activated Matrix Technology Accelerates Periodontal Tissue Regenerat

SAN DIEGO, Sept. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported on preclinical findings published in the...

Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers

Diabetic Foot Ulcers Leading to Amputation Often as Deadly as Many Common Cancers Excellarate Offers Potential for Simpler and Enhanced Treatment...

Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study

Results of Landmark Gene Therapy Study For Non-Healing Diabetic Ulcers Expected to be Announced in Late September 2009 SAN DIEGO, Aug. 25...

Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments

SAN DIEGO, Aug. 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported its financial results for its second quarter...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factor

SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced plans to develop a DNA-based orthobiologics...

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

Cardium Regains Listing Compliance with NYSE Amex

SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) ("Cardium") reported that it has received a letter from the...

Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics

SAN DIEGO, July 24 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) ("Cardium") today announced that it has completed the asset...

Philips Expands Emergency Healthcare Offering With Acquisition of InnerCool Therapies, a Leader in Body Temperature Management

AMSTERDAM and SAN DIEGO, July 15 /PRNewswire-FirstCall/ -- Royal Philips (AEX:PHIAEX:NYSE:AEX:PHG) announced today that it has reached an...

Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting

SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) and its subsidiary Tissue Repair Company (TRC) today announced...

Zadie420 20 seconds ago

Unfortunately the answer is yes if NWBO keep issuing shares. This is deadly scenario in OTC market. LP has just played this to MMs hands.

NWBO

Swampy83 21 seconds ago

More than I.7 billion shares at this price. That's for sure.

RDAR

Bubae 24 seconds ago

You really should post something, anything, to support your statements. You were the rare bird that observed that I was correct with my information to January 2024. The basis for that and company facts behind those posts has not changed. I'm always open to new information, enlighten me. 😉You

BEGI

gp22 44 seconds ago

$ROOT ripping. Exact clones $KINS @ $11s starting to rip. Great low float, cash rich play . A complete clone of $ROOT with better numbers. Reddit/Discord crowd posting about $KINS now. Do not miss $KINS.
Link:
finviz.com/quote.ashx?t=KINS

KINS ROOT

sunspotter 52 seconds ago

I didn’t play with them, silly.

I knew they were a scam from the get/go, just like PKTX which is run by the same French Canadian mafiosi.

Here’s my very first post on the SPPH MB:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=56325141

PKTX

jobynimble 54 seconds ago

Somebody turned on the Verb trading bot, but it’s not helping the share price much…

Two weeks to the third quarter 10-Q…

VERB

arachnodude 57 seconds ago

I would expect a CFP with a master’s degree in financial planning and 20 years of experience would understand why KBLB isn't releasing numbers at this stage. Then again, someone with all that expertise might just be grateful for stock message boards to manage their emotions when their expertise fall

KBLB

BeachBum 1 minute ago

We’re all full of BS. Stay on the sidelines and save yourself from this scam.

PSRU

Golden Cross 1 minute ago

🚀 $ILLR Triller: A Generational Opportunity
🌍 Addressable Market: 8 Billion People
🌟 This is YOUR chance to get in on the ground floor of the next social media revolution.
Don't miss out!

https://www.youtube.com/watch?v=6egwKmcraGk

ILLR

dexprs 1 minute ago

According to the Iowa Poll, Harris is leading by 3 points.
Time to double check on a few Harris stocks, like clean energy and go lighter on Pharmaceuticals. I sold PFE last week.

PFE

ducci1 1 minute ago

Covered 1/2 571C .56!---At the Vix 5 min Red Line Target!

SPY

Filterthenoise 1 minute ago

Ticky Tok FUDsters

RNVA

thesmallguy 1 minute ago

I'm gonna guess this closes at 8 or maybe even 9 today. Too much selling for great news with more to come.

ASII

Fallingknife75 2 minutes ago

A few nice Ask slaps happening. The chart setup here is very nice and a potential huge catalyst is coming (first pour news). Easy accumulate and hold here.

All the best,

Knife

NBRI

PROPHET-of-PROFITS 2 minutes ago

wish they'd inform the market HOW MUCH F'ING DEBT IS LEFT.

RDAR

DiscoverGold 2 minutes ago

$PLTR Palantir Reports Q3 earnings TODAY:
By: TrendSpider | November 4, 2024

• $PLTR Palantir Reports Q3 earnings TODAY:

EPS Estimate: $0.09 (+28.57% YoY)
Revenue Estimate: $703.69M (+25.61% YoY)

The company is aiming for its 16th conse

PLTR

diamondguru-one 2 minutes ago

AND ??? I can WAIT !!!!!!!!!!!!!!!!

GNCP

cardmaster114 2 minutes ago

I agree !!!!!!!!!!!!!!!!!!!

DBMM

manibiotech 2 minutes ago

Mine was .147 I think

NWBO

Diamondhands45 2 minutes ago

We need buying

SPZI

lakers17 2 minutes ago

Wow, disclosing inside info on a social media site that is not privy to everyone. Brilliant by NSAV. And only an idiot would give Discord their personal ID's.

NSAV

Monksdream 3 minutes ago

ARM , 10Q 11/6
https://investorshub.advfn.com/uimage/uploads/2024/11/4/xbnjyIMG_3043.gif

ARM

Golden Cross 3 minutes ago

ILLR

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Centrex Ltd (CXM)

Professional-Grade Tools, for Individual Investors.

CXM News

Cardium Announces Planned Release of Data from Matrix Excellarate Phase 2b Clinical Study and Acceptance of Phase 1 / 2 Study fo

Cardium Announces $4.5 Million Common Stock Private Placement

Scientific Journal Gene Therapy Reports That Cardium's Gene Activated Matrix Technology Accelerates Periodontal Tissue Regenerat

Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers

Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study

Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factor

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

Cardium Regains Listing Compliance with NYSE Amex

Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics

Philips Expands Emergency Healthcare Offering With Acquisition of InnerCool Therapies, a Leader in Body Temperature Management

Cardium's InnerCool Therapies Business to Be Acquired By Royal Philips Electronics

SmallCapSentinel.com Releases Watch List for VPWS, ZN, CHBT, CXM, SMIT, ADY, and PWRD

Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index

Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting

Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Centrex Ltd (CXM) News

Centrex Ltd (CXM)

Professional-Grade Tools, for Individual Investors.

CXM News

Cardium Announces Planned Release of Data from Matrix Excellarate Phase 2b Clinical Study and Acceptance of Phase 1 / 2 Study fo

Cardium Announces $4.5 Million Common Stock Private Placement

Scientific Journal Gene Therapy Reports That Cardium's Gene Activated Matrix Technology Accelerates Periodontal Tissue Regenerat

Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers

Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study

Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factor

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

Cardium Regains Listing Compliance with NYSE Amex

Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics

Philips Expands Emergency Healthcare Offering With Acquisition of InnerCool Therapies, a Leader in Body Temperature Management

Cardium's InnerCool Therapies Business to Be Acquired By Royal Philips Electronics

SmallCapSentinel.com Releases Watch List for VPWS, ZN, CHBT, CXM, SMIT, ADY, and PWRD

Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index

Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting

Discussion

Your Recent History

Company

Business

Popular

Get The App